Roanna Ruiz
Stock Analyst at Leerink Partners
(1.17)
# 3,787
Out of 5,044 analysts
454
Total ratings
45.8%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Reiterated: Buy | $685 | $549.16 | +24.74% | 27 | Oct 1, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $19 → $17 | $11.70 | +45.30% | 35 | Sep 29, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $9 → $16 | $10.48 | +52.67% | 36 | Sep 10, 2026 | |
| SPRY ARS Pharmaceuticals | Reiterated: Buy | $28 → $15 | $4.23 | +254.61% | 28 | Sep 8, 2026 | |
| AKBA Akebia Therapeutics | Downgraded: Hold | $7 → $1 | $0.8011 | +24.83% | 7 | Aug 7, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $99 → $103 | $100.15 | +2.35% | 54 | Aug 3, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $37 | $14.67 | +152.22% | 1 | Jul 13, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $4.78 | +88.28% | 24 | May 15, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 → $15 | $7.38 | +103.25% | 11 | May 15, 2026 | |
| IBIO iBio, Inc. | Reiterated: Buy | $5 → $6 | $0.871 | +588.86% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.29 | - | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $62.91 | - | 30 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $13.19 | +21.30% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $9 | $12.50 | n/a | 37 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 → $2.00 | $0.86 | n/a | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $1.68 | n/a | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $21.58 | n/a | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $3.28 | n/a | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $12.03 | n/a | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $170.54 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $4 | $5.15 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $5.34 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $121.19 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
United Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $685
Current: $549.16
Upside: +24.74%
Vir Biotechnology
Sep 29, 2026
Reiterated: Buy
Price Target: $19 → $17
Current: $11.70
Upside: +45.30%
Xeris Biopharma Holdings
Sep 10, 2026
Reiterated: Buy
Price Target: $9 → $16
Current: $10.48
Upside: +52.67%
ARS Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $28 → $15
Current: $4.23
Upside: +254.61%
Akebia Therapeutics
Aug 7, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.8011
Upside: +24.83%
Lantheus Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: $99 → $103
Current: $100.15
Upside: +2.35%
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $14.67
Upside: +152.22%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $4.78
Upside: +88.28%
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $7.38
Upside: +103.25%
iBio, Inc.
May 15, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $0.871
Upside: +588.86%
Feb 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.29
Upside: -
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $62.91
Upside: -
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $13.19
Upside: +21.30%
Oct 1, 2025
Reiterated: Hold
Price Target: $7 → $9
Current: $12.50
Upside: n/a
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $0.86
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $1.68
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $21.58
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $3.28
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $12.03
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $170.54
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $5 → $4
Current: $5.15
Upside: n/a
May 7, 2024
Reiterated: Hold
Price Target: $25
Current: $5.34
Upside: n/a
Jan 22, 2024
Reiterated: Hold
Price Target: $23
Current: $121.19
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a